| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | UGT1A6 EXTL1 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.49e-13 | 35 | 106 | 9 | GO:0015020 |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | UGT1A6 EXTL1 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.25e-07 | 153 | 106 | 9 | GO:0008194 |
| GeneOntologyMolecularFunction | retinoic acid binding | 3.42e-07 | 28 | 106 | 5 | GO:0001972 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | UGT1A6 EXTL1 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.88e-06 | 211 | 106 | 9 | GO:0016758 |
| GeneOntologyMolecularFunction | glycosyltransferase activity | UGT1A6 EXTL1 PARP10 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 3.14e-06 | 288 | 106 | 10 | GO:0016757 |
| GeneOntologyMolecularFunction | retinoid binding | 5.47e-06 | 48 | 106 | 5 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 6.07e-06 | 49 | 106 | 5 | GO:0019840 | |
| GeneOntologyMolecularFunction | cytoskeletal protein-membrane anchor activity | 1.66e-04 | 4 | 106 | 2 | GO:0106006 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 2.65e-04 | 107 | 106 | 5 | GO:0033293 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 6.12e-14 | 21 | 104 | 8 | GO:0052695 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 3.94e-13 | 8 | 104 | 6 | GO:0070980 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 4.60e-13 | 26 | 104 | 8 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 4.60e-13 | 26 | 104 | 8 | GO:0006063 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 2.93e-12 | 10 | 104 | 6 | GO:0018879 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 1.09e-11 | 37 | 104 | 8 | GO:0042178 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 1.28e-11 | 12 | 104 | 6 | GO:0052697 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 1.99e-10 | 52 | 104 | 8 | GO:0008210 | |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 6.14e-10 | 37 | 104 | 7 | GO:0042537 | |
| GeneOntologyBiologicalProcess | androgen metabolic process | 3.44e-08 | 38 | 104 | 6 | GO:0008209 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | CYP2D6 UGT1A6 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 NOS1 | 3.99e-08 | 141 | 104 | 9 | GO:0006805 |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | CYP2D6 MAP1B UGT1A6 ITGA3 SHANK2 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 ATP1A3 UGT2B11 CDH3 NOS1 | 3.93e-07 | 525 | 104 | 14 | GO:0009410 |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | CYP2D6 UGT1A6 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 NOS1 | 1.87e-06 | 222 | 104 | 9 | GO:0071466 |
| GeneOntologyBiologicalProcess | hormone metabolic process | TPO CYP2D6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.45e-05 | 286 | 104 | 9 | GO:0042445 |
| GeneOntologyBiologicalProcess | steroid metabolic process | CYP2D6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 APOL2 | 1.21e-04 | 376 | 104 | 9 | GO:0008202 |
| GeneOntologyBiologicalProcess | regulation of hormone levels | TPO CYP2D6 STXBP5L CRY1 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 NOS1 | 1.71e-04 | 684 | 104 | 12 | GO:0010817 |
| GeneOntologyCellularComponent | nuclear outer membrane | 1.07e-09 | 40 | 105 | 7 | GO:0005640 | |
| GeneOntologyCellularComponent | organelle outer membrane | SYNE1 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 NOS1 MIEF2 | 1.16e-05 | 279 | 105 | 9 | GO:0031968 |
| GeneOntologyCellularComponent | outer membrane | SYNE1 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 NOS1 MIEF2 | 1.23e-05 | 281 | 105 | 9 | GO:0019867 |
| GeneOntologyCellularComponent | neuron to neuron synapse | MAP1B ARFGEF2 EPB41L3 GRM4 TAMALIN FGF22 PTPRD SHANK2 SYN2 ATP1A3 NOS1 | 6.47e-05 | 523 | 105 | 11 | GO:0098984 |
| GeneOntologyCellularComponent | nuclear membrane | PHF20 SYNE1 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 NOS1 | 6.69e-05 | 349 | 105 | 9 | GO:0031965 |
| GeneOntologyCellularComponent | nuclear envelope | PHF20 SYNE1 TAMALIN MAD1L1 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 NOS1 | 1.19e-04 | 560 | 105 | 11 | GO:0005635 |
| GeneOntologyCellularComponent | asymmetric synapse | 6.74e-04 | 477 | 105 | 9 | GO:0032279 | |
| GeneOntologyCellularComponent | SAGA-type complex | 9.87e-04 | 39 | 105 | 3 | GO:0070461 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.30e-03 | 94 | 105 | 4 | GO:0000123 | |
| GeneOntologyCellularComponent | dendritic spine | 1.40e-03 | 242 | 105 | 6 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 1.56e-03 | 247 | 105 | 6 | GO:0044309 | |
| GeneOntologyCellularComponent | distal axon | 1.58e-03 | 435 | 105 | 8 | GO:0150034 | |
| GeneOntologyCellularComponent | juxtaparanode region of axon | 1.60e-03 | 12 | 105 | 2 | GO:0044224 | |
| GeneOntologyCellularComponent | axon | MAP1B FSCN3 KIF21A ITGA3 EPB41L3 GRM4 IQGAP1 NGDN SPTBN4 SHANK2 ATP1A3 NOS1 | 1.71e-03 | 891 | 105 | 12 | GO:0030424 |
| GeneOntologyCellularComponent | postsynapse | MAP1B SYNE1 ARFGEF2 ITGA3 EPB41L3 TAMALIN CHRNA1 FGF22 NGDN SHANK2 SYN2 ATP1A3 NOS1 | 1.76e-03 | 1018 | 105 | 13 | GO:0098794 |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.88e-03 | 104 | 105 | 4 | GO:0031248 | |
| GeneOntologyCellularComponent | organelle envelope | LYRM7 PHF20 MRPS12 SYNE1 TAMALIN MAD1L1 TIMM50 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 NOS1 MIEF2 ATP5F1B | 2.10e-03 | 1435 | 105 | 16 | GO:0031967 |
| GeneOntologyCellularComponent | acetyltransferase complex | 2.23e-03 | 109 | 105 | 4 | GO:1902493 | |
| GeneOntologyCellularComponent | glutamatergic synapse | MAP1B ARFGEF2 ITGA3 GRM4 TAMALIN FGF22 NGDN PTPRD SHANK2 SYN2 NOS1 | 2.68e-03 | 817 | 105 | 11 | GO:0098978 |
| GeneOntologyCellularComponent | synaptic membrane | 2.69e-03 | 583 | 105 | 9 | GO:0097060 | |
| GeneOntologyCellularComponent | dendritic spine head | 2.86e-03 | 16 | 105 | 2 | GO:0044327 | |
| Domain | UDPGT | 1.15e-13 | 21 | 102 | 8 | PF00201 | |
| Domain | UDPGT | 1.15e-13 | 21 | 102 | 8 | PS00375 | |
| Domain | UDP_glucos_trans | 1.15e-13 | 21 | 102 | 8 | IPR002213 | |
| Domain | Spectrin | 2.59e-04 | 23 | 102 | 3 | PF00435 | |
| Domain | PEROXIDASE_1 | 4.37e-04 | 6 | 102 | 2 | PS00435 | |
| Domain | CH | 4.40e-04 | 65 | 102 | 4 | SM00033 | |
| Domain | Spectrin_repeat | 5.21e-04 | 29 | 102 | 3 | IPR002017 | |
| Domain | CH | 5.83e-04 | 70 | 102 | 4 | PF00307 | |
| Domain | - | 6.15e-04 | 71 | 102 | 4 | 1.10.418.10 | |
| Domain | CH | 6.84e-04 | 73 | 102 | 4 | PS50021 | |
| Domain | SPEC | 6.99e-04 | 32 | 102 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 6.99e-04 | 32 | 102 | 3 | IPR018159 | |
| Domain | CH-domain | 7.57e-04 | 75 | 102 | 4 | IPR001715 | |
| Pathway | REACTOME_GLUCURONIDATION | 7.52e-13 | 25 | 80 | 8 | M17787 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 7.52e-13 | 25 | 80 | 8 | M605 | |
| Pathway | WP_GLUCURONIDATION | 1.08e-12 | 26 | 80 | 8 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 2.13e-12 | 28 | 80 | 8 | M19580 | |
| Pathway | REACTOME_ASPIRIN_ADME | CYP2D6 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 2.32e-12 | 44 | 80 | 9 | M45014 |
| Pathway | REACTOME_GLUCURONIDATION | 4.64e-11 | 24 | 80 | 7 | MM14599 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 6.17e-11 | 41 | 80 | 8 | M7399 | |
| Pathway | WP_GLUCURONIDATION | 6.42e-11 | 25 | 80 | 7 | MM15820 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.37e-10 | 45 | 80 | 8 | MM15694 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | CYP2D6 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 2.45e-10 | 72 | 80 | 9 | M9257 |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 3.93e-10 | 51 | 80 | 8 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 4.62e-10 | 52 | 80 | 8 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 7.38e-10 | 55 | 80 | 8 | M14933 | |
| Pathway | KEGG_RETINOL_METABOLISM | 2.58e-09 | 64 | 80 | 8 | M9488 | |
| Pathway | REACTOME_PREDNISONE_ADME | 2.58e-09 | 23 | 80 | 6 | MM16639 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 5.35e-09 | 70 | 80 | 8 | M16794 | |
| Pathway | REACTOME_DRUG_ADME | CYP2D6 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.04e-08 | 109 | 80 | 9 | M45012 |
| Pathway | REACTOME_PARACETAMOL_ADME | 7.76e-08 | 39 | 80 | 6 | MM15695 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.80e-07 | 109 | 80 | 8 | M18788 | |
| Pathway | REACTOME_DRUG_ADME | 3.55e-07 | 119 | 80 | 8 | MM15692 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | CYP2D6 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 9.03e-07 | 183 | 80 | 9 | M39588 |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 9.22e-07 | 14 | 80 | 4 | M39328 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 2.40e-06 | 107 | 80 | 7 | MM14595 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | CYP2D6 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 4.14e-06 | 220 | 80 | 9 | M10320 |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 3.31e-05 | 219 | 80 | 8 | MM14838 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 2.17e-04 | 21 | 80 | 3 | M39631 | |
| Pathway | WP_G13_SIGNALING | 1.29e-03 | 38 | 80 | 3 | M39606 | |
| Pathway | WP_G13_SIGNALING_PATHWAY | 1.39e-03 | 39 | 80 | 3 | MM15898 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.39e-03 | 10 | 80 | 2 | M46430 | |
| Pubmed | 4.85e-15 | 7 | 106 | 6 | 26074487 | ||
| Pubmed | 1.93e-14 | 8 | 106 | 6 | 32093886 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 1.86e-10 | 12 | 106 | 5 | 20308471 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | LYRM7 CDC42BPA MAP1B STXBP5L HECTD4 ANKMY1 PARVB TTC3 SPTBN4 YEATS2 PHKB PARP10 PXDN SHANK2 MAD1L1 SNTG2 SCAF11 EIF2AK4 MCF2L ZNF839 SCARA3 GOLGB1 | 6.58e-10 | 1489 | 106 | 22 | 28611215 |
| Pubmed | MAP1B SYNE1 KIF21A DHX57 SMC2 EPB41L3 TTC3 CHRNA1 IQGAP1 NGDN SPTBN4 SF3B3 PXDN SHANK2 EIF2AK4 ATP1A3 MCF2L DTHD1 GOLGB1 CCDC158 ATP5F1B | 2.22e-09 | 1442 | 106 | 21 | 35575683 | |
| Pubmed | 5.65e-09 | 8 | 106 | 4 | 22579593 | ||
| Pubmed | 5.65e-09 | 8 | 106 | 4 | 18719240 | ||
| Pubmed | 5.65e-09 | 8 | 106 | 4 | 20142249 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPPK1 CDC42BPA MRPS12 DOCK9 HECTD4 ARFGEF2 PARVB ITGA3 TTC3 HDDC3 SHANK2 ARVCF PIK3CD MAD1L1 HERC1 MCF2L ZNF839 SCARA3 | 6.56e-09 | 1105 | 106 | 18 | 35748872 |
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 19572376 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 7835904 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 29138287 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 28882566 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 23223495 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 22092298 | ||
| Pubmed | 3.96e-08 | 12 | 106 | 4 | 18161889 | ||
| Pubmed | 5.44e-08 | 66 | 106 | 6 | 19898482 | ||
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 16849011 | ||
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 26176234 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.09e-07 | 202 | 106 | 8 | 33005030 | |
| Pubmed | SYNE1 KIF21A HECTD4 SMC2 EPB41L3 GRM4 TTC3 IQGAP1 SPTBN4 PTPRD SHANK2 ARVCF MAD1L1 NOS1 GOLGB1 | 2.40e-07 | 963 | 106 | 15 | 28671696 | |
| Pubmed | 2.74e-07 | 5 | 106 | 3 | 15318931 | ||
| Pubmed | 9.55e-07 | 7 | 106 | 3 | 20056642 | ||
| Pubmed | 1.52e-06 | 8 | 106 | 3 | 10748067 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 34000957 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 10222050 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 32660355 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 33400134 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 28962835 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 1909870 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 17687269 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24121496 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 26233433 | ||
| Pubmed | Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation. | 9.20e-06 | 2 | 106 | 2 | 3117546 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 17263731 | ||
| Pubmed | Extensive metabolic consequences of human glycosyltransferase gene knockouts in prostate cancer. | 9.20e-06 | 2 | 106 | 2 | 36347965 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24267955 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22170718 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 21679149 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 28472154 | ||
| Pubmed | UGT2B7*3 did not affect the pharmacokinetics of R- and S-carvedilol in healthy Japanese. | 9.20e-06 | 2 | 106 | 2 | 17965522 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 18719619 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 21666065 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15319348 | ||
| Pubmed | Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5. | 9.20e-06 | 2 | 106 | 2 | 3105095 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 17848572 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 27496708 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 28228532 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15666817 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 17698910 | ||
| Pubmed | 1.12e-05 | 163 | 106 | 6 | 16512683 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | EPPK1 KIF21A ARFGEF2 PARVB SMC2 EPB41L3 IQGAP1 SF3B3 MAD1L1 GOLGB1 | 1.21e-05 | 582 | 106 | 10 | 20467437 |
| Pubmed | 1.81e-05 | 17 | 106 | 3 | 27779093 | ||
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 2.16e-05 | 183 | 106 | 6 | 31932471 | |
| Pubmed | 2.17e-05 | 18 | 106 | 3 | 20056724 | ||
| Pubmed | Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines. | 2.76e-05 | 3 | 106 | 2 | 26163549 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 20736324 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 26385605 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 27098059 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 8333863 | ||
| Pubmed | Urinary metabolites to assess in vivo ontogeny of hepatic drug metabolism in early neonatal life. | 2.76e-05 | 3 | 106 | 2 | 17609736 | |
| Pubmed | Dendritic spine morphology and memory formation depend on postsynaptic Caskin proteins. | 2.76e-05 | 3 | 106 | 2 | 31727973 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 36250837 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 23099353 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 26407805 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 12623074 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 17329852 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 17988216 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 18496127 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 36571650 | ||
| Pubmed | Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes. | 2.76e-05 | 3 | 106 | 2 | 18302198 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 30689982 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 15952058 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 32176075 | ||
| Pubmed | 2.93e-05 | 116 | 106 | 5 | 30652415 | ||
| Pubmed | MAP1B SYNE1 ARFGEF2 DHX57 EPB41L3 IQGAP1 SPTBN4 PHKB SF3B3 SHANK2 ARVCF SYN2 ATP1A3 NOS1 ATP5F1B | 2.94e-05 | 1431 | 106 | 15 | 37142655 | |
| Pubmed | 3.75e-05 | 202 | 106 | 6 | 24639526 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 26238215 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 10024527 | ||
| Pubmed | Coimmunoprecipitation of UDP-glucuronosyltransferase isoforms and cytochrome P450 3A4. | 5.50e-05 | 4 | 106 | 2 | 15486048 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 17244352 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 22084092 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 18281521 | ||
| Pubmed | 8.47e-05 | 234 | 106 | 6 | 36243803 | ||
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 21846818 | ||
| Pubmed | Neuronal nitric-oxide synthase localization mediated by a ternary complex with synapsin and CAPON. | 9.15e-05 | 5 | 106 | 2 | 11867766 | |
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 17479406 | ||
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 9.19e-05 | 344 | 106 | 7 | 36282215 | |
| Pubmed | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. | 9.66e-05 | 149 | 106 | 5 | 25231870 | |
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 16595916 | ||
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 21365123 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 1.46e-04 | 497 | 106 | 8 | 36774506 | |
| Pubmed | GATD3 SYNE1 KIF21A HECTD4 ARFGEF2 PARVB TTC3 IQGAP1 SPTBN4 UBA7 PTPRD KRT222 ATP5F1B | 1.48e-04 | 1285 | 106 | 13 | 35914814 | |
| Pubmed | 1.73e-04 | 650 | 106 | 9 | 38777146 | ||
| Pubmed | CDC42BPA MAP1B SMC2 IQGAP1 NGDN SF3B3 TIMM50 ASCC3 PRPF39 ATP5F1B | 1.87e-04 | 809 | 106 | 10 | 32129710 | |
| Pubmed | 1.91e-04 | 7 | 106 | 2 | 29949772 | ||
| Pubmed | 1.91e-04 | 7 | 106 | 2 | 16513443 | ||
| Pubmed | 1.91e-04 | 7 | 106 | 2 | 9303529 | ||
| Pubmed | 2.23e-04 | 529 | 106 | 8 | 14621295 | ||
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 2.55e-04 | 8 | 106 | 2 | 12695355 | |
| Cytoband | 4q13 | 3.59e-08 | 15 | 106 | 4 | 4q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 8.77e-08 | 157 | 106 | 7 | chr4q13 | |
| Cytoband | 4q13.2 | 5.13e-05 | 31 | 106 | 3 | 4q13.2 | |
| Cytoband | 2p25 | 7.89e-04 | 18 | 106 | 2 | 2p25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 8.84e-04 | 183 | 106 | 4 | chr16q22 | |
| Cytoband | 10q25.3 | 2.06e-03 | 29 | 106 | 2 | 10q25.3 | |
| Cytoband | 16q22.1 | 2.16e-03 | 110 | 106 | 3 | 16q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p25 | 3.24e-03 | 127 | 106 | 3 | chr2p25 | |
| GeneFamily | UDP glucuronosyltransferases | 5.19e-13 | 32 | 74 | 8 | 363 | |
| GeneFamily | PDZ domain containing | 3.97e-04 | 152 | 74 | 5 | 1220 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | CYP2D6 UGT2A3 MAD1L1 UGT2B4 UGT2B7 UGT2B15 UGT2B17 SNTG2 UGT2B28 UGT2B11 | 5.51e-09 | 190 | 106 | 10 | MM1311 |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4 | CYP2D6 PTPRD UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 APOL2 | 9.56e-07 | 330 | 106 | 10 | MM1120 |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 1.65e-06 | 201 | 106 | 8 | MM1294 | |
| Coexpression | VANLOO_SP3_TARGETS_DN | 3.95e-06 | 103 | 106 | 6 | MM919 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_DN | 1.00e-05 | 121 | 106 | 6 | MM935 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_UP | 1.75e-05 | 200 | 106 | 7 | M4497 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | 5.96e-05 | 166 | 106 | 6 | M2398 | |
| Coexpression | WENG_POR_TARGETS_LIVER_UP | 6.35e-05 | 53 | 106 | 4 | MM1203 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-10 | 195 | 105 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.79e-08 | 191 | 105 | 8 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.94e-08 | 193 | 105 | 8 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-08 | 195 | 105 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.36e-08 | 198 | 105 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.36e-08 | 198 | 105 | 8 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.36e-08 | 198 | 105 | 8 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.55e-08 | 200 | 105 | 8 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 2.77e-07 | 184 | 105 | 7 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-07 | 186 | 105 | 7 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.32e-07 | 189 | 105 | 7 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.44e-07 | 190 | 105 | 7 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.44e-07 | 190 | 105 | 7 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|World / Lineage, Cell type, age group and donor | 3.69e-07 | 192 | 105 | 7 | 1e156bab5ecf64627890d2de9b27603d9a01f28d | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.96e-07 | 194 | 105 | 7 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.54e-07 | 198 | 105 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.70e-07 | 199 | 105 | 7 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.74e-06 | 166 | 105 | 6 | f7926ee266dcbf10df375cd921f1db5a2fa604f8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.23e-06 | 179 | 105 | 6 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.51e-06 | 181 | 105 | 6 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.66e-06 | 182 | 105 | 6 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-06 | 187 | 105 | 6 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-06 | 189 | 105 | 6 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.96e-06 | 190 | 105 | 6 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 6.14e-06 | 191 | 105 | 6 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-06 | 191 | 105 | 6 | 116fba9badea093e11f370996247cca0e4c02e8f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-06 | 191 | 105 | 6 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.33e-06 | 192 | 105 | 6 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.52e-06 | 193 | 105 | 6 | ad2df9b77999780860141be6ec366afc0172a331 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 6.52e-06 | 193 | 105 | 6 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 6.72e-06 | 194 | 105 | 6 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.72e-06 | 194 | 105 | 6 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.72e-06 | 194 | 105 | 6 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 6.92e-06 | 195 | 105 | 6 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.12e-06 | 196 | 105 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Fetal_29-31_weeks-Endothelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.12e-06 | 196 | 105 | 6 | 3981f6c7487598f4f7ce4650ac0ac5bd41481d66 | |
| ToppCell | Endothelial|World / Lineage, Cell type, age group and donor | 7.12e-06 | 196 | 105 | 6 | 96c6d78482a130ce4e29f6629972a06d10d7530e | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 7.12e-06 | 196 | 105 | 6 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | Endothelial-capillary_endothelial_cell_(Cap1)|World / Lineage, Cell type, age group and donor | 7.12e-06 | 196 | 105 | 6 | 0ce3ed27d2b9276390952652c17a8d6de13add36 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.33e-06 | 197 | 105 | 6 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 7.33e-06 | 197 | 105 | 6 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 7.33e-06 | 197 | 105 | 6 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.77e-06 | 199 | 105 | 6 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.77e-06 | 199 | 105 | 6 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.99e-06 | 200 | 105 | 6 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.99e-06 | 200 | 105 | 6 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.99e-06 | 200 | 105 | 6 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 7.99e-06 | 200 | 105 | 6 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-gd_T|ICU-NoSEP / Disease, condition lineage and cell class | 7.99e-06 | 200 | 105 | 6 | 2c2cea7691c340912f6ad77667a580a071eaeb8b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Cortical_neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 7.99e-06 | 200 | 105 | 6 | 44bc4d6616fc8d0ad8498e56125939034e8cff01 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.99e-06 | 200 | 105 | 6 | f15fffefe372005c33e31845982e2d2714ac26af | |
| ToppCell | distal-Endothelial-Capillary_Intermediate_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.99e-06 | 200 | 105 | 6 | 43bc48413b100a06f8edd9acd812296788fcbf5b | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.99e-06 | 200 | 105 | 6 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.99e-06 | 200 | 105 | 6 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.99e-06 | 200 | 105 | 6 | 3585484c7e24e941708bee471ca607d8ccee74e6 | |
| ToppCell | distal-Endothelial-Capillary_Intermediate_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.99e-06 | 200 | 105 | 6 | 4d6714d48738cdee7d535923f6dd2431e5304741 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 7.99e-06 | 200 | 105 | 6 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | Control-Endothelial_cells-Inflamed_endothelial_cells|Control / group, cell type (main and fine annotations) | 3.87e-05 | 160 | 105 | 5 | 958256e3d3836160763b82bb48f794087918d935 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.17e-05 | 170 | 105 | 5 | ce79f5d0d475fcb6c5a61c94938c65210b3c59d9 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.31e-05 | 171 | 105 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.46e-05 | 172 | 105 | 5 | 3b9be685fcd1634498a603b692f5ac6ddd0de176 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.93e-05 | 175 | 105 | 5 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | Thalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.09e-05 | 176 | 105 | 5 | d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.09e-05 | 176 | 105 | 5 | 72a2a01618ce836bc843395d5095e9090759b4a6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.09e-05 | 176 | 105 | 5 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-05 | 177 | 105 | 5 | 227d4f423b00be2e0c5797e2c5275d342e69a0f4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-05 | 177 | 105 | 5 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-05 | 177 | 105 | 5 | 66ffa279147961080c104242a08b176e301d80e3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-05 | 177 | 105 | 5 | 0cbf54608d2ba0a0500af142f2029fe5e118c3c2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.43e-05 | 178 | 105 | 5 | 431e7557b8e8764e16e9e48368ce6bfa3c61561a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-05 | 179 | 105 | 5 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-05 | 179 | 105 | 5 | f65889bf1e41396979cce44a5e63f49dea2bbd9b | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 6.77e-05 | 180 | 105 | 5 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | Endothelial-A-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 6.77e-05 | 180 | 105 | 5 | 4c3376169770ee9f9283daae44c17f35e46bfd19 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.77e-05 | 180 | 105 | 5 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.95e-05 | 181 | 105 | 5 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.95e-05 | 181 | 105 | 5 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.14e-05 | 182 | 105 | 5 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.14e-05 | 182 | 105 | 5 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.14e-05 | 182 | 105 | 5 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.32e-05 | 183 | 105 | 5 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.32e-05 | 183 | 105 | 5 | ce8be9418b473ea94ec806edc7a2078cc30c1703 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.32e-05 | 183 | 105 | 5 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 7.51e-05 | 184 | 105 | 5 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-05 | 186 | 105 | 5 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.91e-05 | 186 | 105 | 5 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.11e-05 | 187 | 105 | 5 | 218c9b4f28499389c43005d9626af2ac01066027 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.11e-05 | 187 | 105 | 5 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 8.11e-05 | 187 | 105 | 5 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.11e-05 | 187 | 105 | 5 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 8.11e-05 | 187 | 105 | 5 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class | 8.11e-05 | 187 | 105 | 5 | 54d7588172ac145ff5045ad9771636729ca3f0ca | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 8.11e-05 | 187 | 105 | 5 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.11e-05 | 187 | 105 | 5 | c7ac4b328efc2ebb72f71154661914193ff402ca | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 8.32e-05 | 188 | 105 | 5 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-05 | 188 | 105 | 5 | 61f010c165826b434ca3d27553d4c9e13d2c0c51 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.32e-05 | 188 | 105 | 5 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-05 | 188 | 105 | 5 | 7553ef7de3575af4cf34704b405b551c1af8eb83 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.32e-05 | 188 | 105 | 5 | fe7143c36e4a883745862d3c3147cf751b440e46 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.32e-05 | 188 | 105 | 5 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| Computational | Genes in the cancer module 227. | 2.13e-06 | 15 | 70 | 4 | MODULE_227 | |
| Computational | Steroid hormone and heme metabolism. | 1.39e-04 | 16 | 70 | 3 | MODULE_505 | |
| Drug | C1 11-32 | 6.57e-15 | 18 | 105 | 8 | CID000443077 | |
| Drug | C11131 | 6.57e-15 | 18 | 105 | 8 | CID000443076 | |
| Drug | T4-G | 1.13e-14 | 19 | 105 | 8 | CID000152424 | |
| Drug | estriol-16-glucuronide | 3.02e-14 | 21 | 105 | 8 | CID000122281 | |
| Drug | estradiol-3-glucuronide | 7.22e-14 | 23 | 105 | 8 | CID000066651 | |
| Drug | harmol | UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 MCF2L UGT2B11 | 1.61e-13 | 40 | 105 | 9 | CID000068094 |
| Drug | 7-hydroxycoumarin glucuronide | 6.18e-13 | 29 | 105 | 8 | CID000125641 | |
| Drug | AC1Q6OQG | 1.97e-12 | 33 | 105 | 8 | CID000009686 | |
| Drug | 16-epiestriol | GATD3 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 NOS1 | 2.38e-12 | 77 | 105 | 10 | CID000003269 |
| Drug | AC1NOWCJ | 3.31e-12 | 35 | 105 | 8 | CID005120112 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 3.31e-12 | 35 | 105 | 8 | CID010436171 | |
| Drug | estrone-3-glucuronide | 3.31e-12 | 35 | 105 | 8 | CID000115255 | |
| Drug | testosterone glucuronide | 1.31e-11 | 41 | 105 | 8 | CID000108192 | |
| Drug | androsterone glucuronide | 1.98e-11 | 43 | 105 | 8 | CID000114833 | |
| Drug | Meldola | UGT1A6 UBA7 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 2.62e-11 | 68 | 105 | 9 | CID000081507 |
| Drug | L-idaro-1,4-lactone | 3.96e-11 | 28 | 105 | 7 | CID000078997 | |
| Drug | 2,2,2-trichloroethanol | CYP2D6 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 5.06e-11 | 73 | 105 | 9 | CID000008259 |
| Drug | benzyloxyresorufin | CYP2D6 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 9.32e-11 | 78 | 105 | 9 | CID000114982 |
| Drug | AC1NQGK1 | 9.93e-11 | 52 | 105 | 8 | CID005195977 | |
| Drug | oxazepam | 1.16e-10 | 53 | 105 | 8 | CID000004616 | |
| Drug | BP-3,6-quinol | 1.40e-10 | 33 | 105 | 7 | CID000119292 | |
| Drug | phenolphthalein | 2.47e-10 | 58 | 105 | 8 | CID000004764 | |
| Drug | pentoxyresorufin | CYP2D6 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 2.53e-10 | 87 | 105 | 9 | CID000107683 |
| Drug | urochloralic acid | 2.85e-10 | 59 | 105 | 8 | CID003036914 | |
| Drug | 4-hydroxybiphenyl | 2.85e-10 | 59 | 105 | 8 | CID000007103 | |
| Drug | SN-38G | 2.85e-10 | 59 | 105 | 8 | CID000443154 | |
| Drug | UDP-alpha-d-xylopyranose | 3.27e-10 | 60 | 105 | 8 | CID000001165 | |
| Drug | l-borneol | 3.33e-10 | 37 | 105 | 7 | CID000010049 | |
| Drug | p-nitroanisole | CYP2D6 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 4.21e-10 | 92 | 105 | 9 | CID000007485 |
| Drug | 2-naphthol | CYP2D6 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 4.64e-10 | 93 | 105 | 9 | CID000008663 |
| Drug | 3-OHBaP | 4.90e-10 | 63 | 105 | 8 | CID000025890 | |
| Drug | DCNB | UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 MCF2L UGT2B11 | 5.63e-10 | 95 | 105 | 9 | CID000007443 |
| Drug | 2-AF | 7.16e-10 | 41 | 105 | 7 | CID000005800 | |
| Drug | 7,8-benzoquinoline | 1.02e-09 | 43 | 105 | 7 | CID000009191 | |
| Drug | methoxyresorufin | 1.03e-09 | 69 | 105 | 8 | CID000119220 | |
| Drug | aniline | CYP2D6 SYNE1 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.13e-09 | 142 | 105 | 10 | CID000006115 |
| Drug | MS-222 | 1.21e-09 | 44 | 105 | 7 | CID000011400 | |
| Drug | Hymecromone | 1.37e-09 | 25 | 105 | 6 | ctd:D006923 | |
| Drug | 7-hydroxycoumarin | 2.04e-09 | 75 | 105 | 8 | CID005281426 | |
| Drug | licochalcone A | 2.28e-09 | 27 | 105 | 6 | ctd:C070840 | |
| Drug | salicylamide | 2.28e-09 | 48 | 105 | 7 | CID000005147 | |
| Drug | AC1N8H7N | 2.80e-09 | 78 | 105 | 8 | CID004318740 | |
| Drug | AC1Q7AUJ | CYP2D6 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 3.64e-09 | 117 | 105 | 9 | CID000003303 |
| Drug | AC1LCF1F | CYP2D6 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 MCF2L UGT2B11 | 3.83e-09 | 161 | 105 | 10 | CID000627275 |
| Drug | alpha-naphthoflavone | CYP2D6 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 3.92e-09 | 118 | 105 | 9 | CID000011790 |
| Drug | benzphetamine | CYP2D6 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 4.23e-09 | 119 | 105 | 9 | CID000002341 |
| Drug | lorcaserin | 6.36e-09 | 6 | 105 | 4 | ctd:C506658 | |
| Drug | aminopyrine | TPO CYP2D6 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 6.84e-09 | 171 | 105 | 10 | CID000006009 |
| Drug | hexobarbital | CYP2D6 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 7.52e-09 | 127 | 105 | 9 | CID000003608 |
| Drug | 7-methoxycoumarin | 7.93e-09 | 57 | 105 | 7 | CID000010748 | |
| Drug | 4-hydroxyestrone | 1.02e-08 | 59 | 105 | 7 | CID000018418 | |
| Drug | acetaminophen glucuronide | 1.02e-08 | 59 | 105 | 7 | CID000083944 | |
| Drug | 2-methoxyestradiol | UGT1A6 ARFGEF2 SF3B3 ARVCF UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.24e-08 | 236 | 105 | 11 | CID000001573 |
| Drug | ethoxyresorufin | 1.36e-08 | 95 | 105 | 8 | CID000003294 | |
| Drug | 1-naphthol | 1.74e-08 | 98 | 105 | 8 | CID000007005 | |
| Drug | uridine 5'-diphosphoglucuronic acid | TPO MRPS12 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.78e-08 | 189 | 105 | 10 | CID000000390 |
| Drug | 3-hydroxyandrostan-17-one | 2.39e-08 | 102 | 105 | 8 | CID000000225 | |
| Drug | AC1L1OBF | 2.78e-08 | 20 | 105 | 5 | CID000032736 | |
| Drug | fluconazole | 3.49e-08 | 107 | 105 | 8 | CID000003365 | |
| Drug | eugenol | 4.60e-08 | 73 | 105 | 7 | CID000003314 | |
| Drug | lithocholic acid | 6.57e-08 | 116 | 105 | 8 | CID000009903 | |
| Drug | estrone-d4 | UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 NOS1 | 8.57e-08 | 168 | 105 | 9 | CID000000698 |
| Drug | acridine | 9.52e-08 | 81 | 105 | 7 | CID000009215 | |
| Drug | glucosiduronate | TPO UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 9.98e-08 | 171 | 105 | 9 | CID000000610 |
| Drug | 3-methylcholanthrene | CYP2D6 UGT1A6 SPAG7 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.18e-07 | 231 | 105 | 10 | CID000001674 |
| Drug | 5 alpha-androstane | 1.23e-07 | 84 | 105 | 7 | CID000094144 | |
| Drug | 4-nitrophenol | CYP2D6 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.34e-07 | 177 | 105 | 9 | CID000000980 |
| Drug | 7-ethoxycoumarin | 1.44e-07 | 86 | 105 | 7 | CID000035703 | |
| Drug | menthol | 1.56e-07 | 87 | 105 | 7 | CID000001254 | |
| Drug | 3 alpha,6 alpha-dihydroxy-5 beta-cholanoic acid | 2.06e-07 | 29 | 105 | 5 | CID000006747 | |
| Drug | 4-aminobiphenyl | 2.30e-07 | 92 | 105 | 7 | CID000007102 | |
| Drug | DNCB | UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 MCF2L UGT2B11 | 2.34e-07 | 189 | 105 | 9 | CID000000006 |
| Drug | phenolate | SYNE1 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 NOS1 | 2.85e-07 | 254 | 105 | 10 | CID000000996 |
| Drug | AC1L7AJI | UGT1A6 PTPRD UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 CDH3 | 3.06e-07 | 256 | 105 | 10 | CID000003750 |
| Drug | DB04103 | 3.31e-07 | 97 | 105 | 7 | CID004469987 | |
| Drug | NNAL | 3.46e-07 | 32 | 105 | 5 | CID000104856 | |
| Drug | 2 E1 | 3.69e-07 | 145 | 105 | 8 | CID006102788 | |
| Drug | beta-naphthoflavone | CYP2D6 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 3.78e-07 | 200 | 105 | 9 | CID000002361 |
| Drug | R(-)-Denopamine | 4.06e-07 | 33 | 105 | 5 | CID000003818 | |
| Drug | UDP-N-acetylglucosamine | UGT1A6 EXTL1 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 4.28e-07 | 203 | 105 | 9 | CID000001167 |
| Drug | acetaminophen | TPO CYP2D6 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 4.99e-07 | 270 | 105 | 10 | CID000001983 |
| Drug | chrysin | 6.07e-07 | 106 | 105 | 7 | CID005281607 | |
| Drug | Aroclor 1254 | CYP2D6 UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 6.41e-07 | 213 | 105 | 9 | CID000040470 |
| Drug | disulfiram | UGT1A6 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 ATP5F1B | 7.10e-07 | 158 | 105 | 8 | CID000003117 |
| Drug | 2-naphthylamine | 7.81e-07 | 110 | 105 | 7 | CID000007057 | |
| Drug | phenolphthalin | 9.47e-07 | 5 | 105 | 3 | CID000066494 | |
| Drug | hyodeoxycholic acid | 9.47e-07 | 5 | 105 | 3 | ctd:C010471 | |
| Drug | Amobarbital | 9.47e-07 | 5 | 105 | 3 | ctd:D000654 | |
| Drug | al-Badry | 9.86e-07 | 165 | 105 | 8 | CID000004545 | |
| Drug | ethoxyquin | 1.12e-06 | 116 | 105 | 7 | CID000003293 | |
| Drug | fibrates | 1.26e-06 | 118 | 105 | 7 | CID000002797 | |
| Drug | thryroxine | TPO UGT1A6 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 ATP1A3 UGT2B11 | 1.38e-06 | 302 | 105 | 10 | CID000000853 |
| Drug | UDP - Na | UGT1A6 EXTL1 UGT2A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.45e-06 | 235 | 105 | 9 | CID000001158 |
| Drug | SN-38 | 2.23e-06 | 184 | 105 | 8 | CID000104842 | |
| Drug | morphine hydrochloride | CYP2D6 UGT1A6 GRM4 TAMALIN UGT2A3 UGT2B4 UGT2B7 UGT2B15 SYN2 UGT2B17 UGT2B28 UGT2B11 | 2.27e-06 | 481 | 105 | 12 | CID000004253 |
| Drug | AC1L1FK5 | 2.28e-06 | 129 | 105 | 7 | CID000003272 | |
| Drug | 4-methylumbelliferone | 2.66e-06 | 132 | 105 | 7 | CID003364573 | |
| Drug | ranirestat | 3.29e-06 | 7 | 105 | 3 | ctd:C115070 | |
| Drug | scopoletin | 3.40e-06 | 50 | 105 | 5 | CID005280460 | |
| Drug | oltipraz | 3.41e-06 | 137 | 105 | 7 | CID000047318 | |
| Disease | X-19141 measurement | 6.52e-10 | 13 | 105 | 5 | EFO_0800799 | |
| Disease | X-24947 measurement | 1.30e-08 | 22 | 105 | 5 | EFO_0800910 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 1.88e-08 | 9 | 105 | 4 | EFO_0600040 | |
| Disease | deoxycholic acid glucuronide measurement | 2.42e-06 | 8 | 105 | 3 | EFO_0800575 | |
| Disease | vitamin D deficiency | 9.13e-06 | 37 | 105 | 4 | EFO_0003762 | |
| Disease | phosphatidylcholine 36:4 measurement | 3.44e-05 | 18 | 105 | 3 | EFO_0010382 | |
| Disease | cholic acid glucuronide measurement | 3.75e-05 | 3 | 105 | 2 | EFO_0800574 | |
| Disease | androsterone glucuronide measurement | 4.78e-05 | 20 | 105 | 3 | EFO_0800317 | |
| Disease | non-high density lipoprotein cholesterol measurement | UGT1A6 RNF135 ARFGEF2 NHLRC2 PRKAG3 PARP10 UGT2B15 UGT2B17 ASCC3 APOL2 HYDIN | 4.83e-05 | 713 | 105 | 11 | EFO_0005689 |
| Disease | disease progression measurement | 6.76e-05 | 61 | 105 | 4 | EFO_0008336 | |
| Disease | X-25937 measurement | 7.49e-05 | 4 | 105 | 2 | EFO_0800937 | |
| Disease | mean arterial pressure | ARHGAP42 HECTD4 NHLRC2 TENT5B YEATS2 PTPRD EIF2AK4 NMT1 MIEF2 | 7.52e-05 | 499 | 105 | 9 | EFO_0006340 |
| Disease | response to placebo | 1.25e-04 | 5 | 105 | 2 | EFO_0008344 | |
| Disease | periventricular nodular heterotopia (is_implicated_in) | 1.86e-04 | 6 | 105 | 2 | DOID:0050454 (is_implicated_in) | |
| Disease | forced expiratory volume, response to bronchodilator | 1.96e-04 | 445 | 105 | 8 | EFO_0004314, GO_0097366 | |
| Disease | post-traumatic stress disorder symptom measurement | 2.14e-04 | 82 | 105 | 4 | EFO_0008535 | |
| Disease | vanillylmandelate (VMA) measurement | 2.60e-04 | 7 | 105 | 2 | EFO_0800119 | |
| Disease | X-24574 measurement | 2.60e-04 | 7 | 105 | 2 | EFO_0800897 | |
| Disease | X-24418 measurement | 2.60e-04 | 7 | 105 | 2 | EFO_0800879 | |
| Disease | Periventricular Nodular Heterotopia | 2.60e-04 | 7 | 105 | 2 | C1868720 | |
| Disease | epilepsy (implicated_via_orthology) | 2.99e-04 | 163 | 105 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | obsolete_red blood cell distribution width | ARHGAP42 HECTD4 ZNF407 PARVB IQGAP1 PARP10 UGT2A3 UGT2B15 SYN2 EIF2AK4 HERC1 APOL2 NMT1 CDH3 | 3.01e-04 | 1347 | 105 | 14 | EFO_0005192 |
| Disease | serum N-desmethylclozapine measurement | 3.46e-04 | 8 | 105 | 2 | EFO_0600043 | |
| Disease | Schizophrenia and related disorders | 4.44e-04 | 9 | 105 | 2 | C0809983 | |
| Disease | X-12844 measurement | 4.44e-04 | 9 | 105 | 2 | EFO_0021339 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 4.71e-04 | 276 | 105 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 5.54e-04 | 10 | 105 | 2 | EFO_0022090 | |
| Disease | carboxypeptidase B2 measurement | 5.54e-04 | 10 | 105 | 2 | EFO_0008069 | |
| Disease | C-X-C motif chemokine 10 measurement | 6.32e-04 | 109 | 105 | 4 | EFO_0008056 | |
| Disease | estradiol measurement | 6.54e-04 | 110 | 105 | 4 | EFO_0004697 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 6.76e-04 | 11 | 105 | 2 | EFO_0801531 | |
| Disease | endometrial carcinoma, endometriosis | 6.76e-04 | 11 | 105 | 2 | EFO_0001065, EFO_1001512 | |
| Disease | plasma N-desmethylclozapine measurement | 6.76e-04 | 11 | 105 | 2 | EFO_0600039 | |
| Disease | SCHIZOPHRENIA | 6.76e-04 | 11 | 105 | 2 | 181500 | |
| Disease | vitamin D measurement, COVID-19 | 7.16e-04 | 49 | 105 | 3 | EFO_0004631, MONDO_0100096 | |
| Disease | biliverdin measurement | 8.09e-04 | 12 | 105 | 2 | EFO_0021033 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 8.09e-04 | 12 | 105 | 2 | EFO_0800291 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 8.21e-04 | 307 | 105 | 6 | EFO_0004612, EFO_0020946 | |
| Disease | cardiomyopathy (biomarker_via_orthology) | 9.54e-04 | 13 | 105 | 2 | DOID:0050700 (biomarker_via_orthology) | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 9.54e-04 | 13 | 105 | 2 | EFO_0800293 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 1.11e-03 | 14 | 105 | 2 | EFO_0800283 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 1.19e-03 | 330 | 105 | 6 | EFO_0004529, EFO_0004612 | |
| Disease | infant head circumference | 1.28e-03 | 15 | 105 | 2 | EFO_0004577 | |
| Disease | vitamin D measurement | 1.30e-03 | 336 | 105 | 6 | EFO_0004631 | |
| Disease | vision disorder | 1.46e-03 | 16 | 105 | 2 | MONDO_0021084 | |
| Disease | Bipolar Disorder | 1.61e-03 | 477 | 105 | 7 | C0005586 | |
| Disease | bipolar I disorder | 1.64e-03 | 141 | 105 | 4 | EFO_0009963 | |
| Disease | partial epilepsy | 1.65e-03 | 17 | 105 | 2 | EFO_0004263 | |
| Disease | Dystonia, Limb | 1.65e-03 | 17 | 105 | 2 | C0751093 | |
| Disease | Dystonia, Diurnal | 1.65e-03 | 17 | 105 | 2 | C0393610 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.80e-03 | 243 | 105 | 5 | EFO_0004612, EFO_0020944 | |
| Disease | calcium measurement | 1.84e-03 | 628 | 105 | 8 | EFO_0004838 | |
| Disease | Dystonia, Paroxysmal | 1.85e-03 | 18 | 105 | 2 | C0393588 | |
| Disease | late-onset myasthenia gravis | 1.85e-03 | 18 | 105 | 2 | EFO_1001490 | |
| Disease | Schizophrenia | 1.85e-03 | 18 | 105 | 2 | cv:C0036341 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 1.85e-03 | 18 | 105 | 2 | EFO_0800288 | |
| Disease | urinary metabolite measurement | 1.86e-03 | 245 | 105 | 5 | EFO_0005116 | |
| Disease | etiocholanolone glucuronide measurement | 2.06e-03 | 19 | 105 | 2 | EFO_0800362 | |
| Disease | high density lipoprotein particle size measurement | 3.24e-03 | 170 | 105 | 4 | EFO_0008592 | |
| Disease | alkaline phosphatase measurement | SUPT3H FHIP2A PHKB UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B11 APOL2 GOLGB1 | 3.36e-03 | 1015 | 105 | 10 | EFO_0004533 |
| Disease | coronary artery disease | ARHGAP42 MAP1B DOCK9 HECTD4 ARFGEF2 SEMA5A SF3B3 ARVCF MAD1L1 SCAF11 MCF2L | 3.52e-03 | 1194 | 105 | 11 | EFO_0001645 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALAEEVEQVHRGTTI | 101 | Q9BQE5 | |
| IIDHGLQTLTHEVIV | 481 | O00192 | |
| DSIVVDILVEHISGV | 371 | Q9P2K8 | |
| IDGLSVERNHVLVRI | 861 | Q96NH3 | |
| VLVDETQHLLGVVSL | 456 | Q9UGI9 | |
| VLHLEEVAEGAVTIL | 321 | Q14833 | |
| HIEIHEGTILQTVRT | 151 | Q9Y6D5 | |
| VLEVAQHLGESTVRT | 96 | P06576 | |
| HGEDILASVEQITIV | 191 | Q8N7S6 | |
| EVFIVTGHTVLEVRE | 716 | P98198 | |
| VVQEEHERILAIGLI | 531 | P46940 | |
| PVEDHRQVVEVTVGL | 41 | P02708 | |
| VVVGEIVTEEHLRRA | 41 | P46821 | |
| IVTEEHLRRAIGNIE | 46 | P46821 | |
| VGELIEVHLRRQDSI | 686 | Q9Y6D9 | |
| EITRRVHLEGIFQAV | 266 | P30419 | |
| RILTHEAGITDIVVL | 41 | Q8N4P3 | |
| VLRGVEVTVGHEQEE | 186 | A0A0B4J2D5 | |
| VIIEDVAVGAEHTLA | 4291 | Q15751 | |
| EVIGVTLHTRDLQVQ | 721 | P26006 | |
| QVEIESLHAVERGLE | 66 | Q8N1A0 | |
| REVTRHVIQVSNEVV | 206 | P07202 | |
| VTLGRHVEQLVESVF | 461 | Q8TDF6 | |
| HVSLTRLTDGENVVV | 121 | Q8N8W4 | |
| DEVTLTVGSVNLEIH | 121 | Q13651 | |
| DSILEIRSVHVGVVV | 71 | Q9HCT0 | |
| LHGVVLDVDSVNELV | 2371 | Q9Y4D8 | |
| LNVEGIRHREIVDII | 161 | Q7Z6J2 | |
| LNVRAGDVITVLEQH | 301 | Q8WXE0 | |
| VDQVTDRLVIADTGH | 231 | Q8NBF2 | |
| EFEIENGTHERVVVL | 361 | Q86UA1 | |
| DVELLLRTSVIQGIH | 61 | Q5U5X0 | |
| LEVLRGIASETHVVL | 81 | P29475 | |
| EHVTVQVVVVRKREG | 201 | Q9HBI1 | |
| LVGVETSHLELVESI | 141 | Q6PIJ6 | |
| IVSEDGLIITNAHVV | 206 | P83105 | |
| LVLETQVTGEHRSTV | 766 | Q4G0P3 | |
| EVAVNVTRVIIHVVA | 886 | Q9BZ29 | |
| EEILTARGEQVHRVA | 126 | Q5SXM8 | |
| TTAVIHEVQRFGDIV | 356 | P10635 | |
| DTALQGVSHIIVDEV | 656 | Q6P158 | |
| LHVQEITVRGEIQTL | 711 | Q6MZW2 | |
| LATEAGVEVIVRISH | 116 | Q16526 | |
| VVIIDEAHNLIDTIT | 391 | A8MPP1 | |
| EILVSNEHETQAVVR | 51 | Q9NQT6 | |
| EGVQIVELLLHAITD | 596 | Q9P2S6 | |
| REETHGIIQTTETEI | 111 | Q6ZMT9 | |
| ETDHQIDVSDVIRLV | 31 | O15068 | |
| IEIEHFIQLITGVAV | 276 | P13637 | |
| VLRGVEVTVGHEQEE | 186 | P0DPI2 | |
| SHEGVLQEIRSILVD | 181 | Q5M9N0 | |
| QLISEHEVEITGLTE | 271 | Q5M9N0 | |
| IIDHITLLEGVIVLE | 731 | Q5W0V3 | |
| EVQLLGHVETEDVEI | 631 | Q99590 | |
| VDTQHGEILRNVTIL | 441 | Q6AZY7 | |
| AVGHEVQRLTVTDLD | 341 | P22223 | |
| VVQETVLVEERRVVH | 851 | Q9Y2J2 | |
| VHVDRLQTLISGAVV | 651 | Q93100 | |
| THDEREAVIQQELVI | 841 | Q93100 | |
| LRAALEVHVQEETVG | 726 | Q53GL7 | |
| THGLVQVTLLDTVEL | 1476 | P23468 | |
| ATHQLLGDVQRVIEV | 741 | Q9BVI0 | |
| TLEEVSRLGLQEHVI | 1426 | Q9Y6R4 | |
| EVQHERLELTVAVLV | 291 | Q96C03 | |
| GEHQVEDRQLITELV | 396 | Q92777 | |
| ITEVAQELTELVEHL | 131 | Q8IUD6 | |
| QELTELVEHLVDIVR | 136 | Q8IUD6 | |
| IERSILHDVVEVAGL | 76 | O75391 | |
| AEVALREEITVQQVH | 421 | Q8NF91 | |
| FDIEVVERHGIITLQ | 341 | A6NI28 | |
| STVLREVLVHIVTEV | 991 | Q9NTG1 | |
| EQRLGALAIHTEVVE | 11 | A6NEY8 | |
| RVTVHQLLEAGIIDQ | 886 | P58107 | |
| EVVHLLRNAGDEVTI | 136 | Q9NY99 | |
| VVHVTKDEIIRVGDN | 1251 | Q5VT25 | |
| VIHTTLEVIQDRIFG | 361 | Q92935 | |
| HEITTEIVSLEVRLQ | 546 | Q9Y2K9 | |
| TLQEHQIVLVEGGRT | 101 | O15235 | |
| IVQVVRSTLEEQGLH | 86 | Q96A09 | |
| ESQGNTLVIRVVIHD | 51 | Q9UPX8 | |
| AVDVVQGREALVHII | 406 | Q13591 | |
| QLVQHILGTEDLIVE | 21 | Q6PD74 | |
| QVTILIIDEIHLLGE | 1446 | Q8N3C0 | |
| IALNGVEDVRTVLEH | 286 | Q3ZCQ8 | |
| ETAVLVEDVVHTQLI | 46 | O75486 | |
| QGHDAVLRLVEIRTV | 81 | Q8NEJ9 | |
| AVQVVVHTGDITEDL | 101 | P41226 | |
| TILDELVQRGHEVTV | 41 | P06133 | |
| IVEEELGIISRAVKH | 106 | Q7Z4S6 | |
| GEIFERTLQLIQEHV | 676 | Q92626 | |
| GEVQVRRAAIHVVVL | 1011 | Q9C0B7 | |
| LSIDEIVQRVTEHIL | 1881 | P53804 | |
| VHVTEEEQLQLREIL | 501 | O00329 | |
| RVLDVNHTVQELVEG | 936 | Q9H254 | |
| VAVLEHQLVEVEETV | 151 | Q6ZMU5 | |
| TILKELVQRGHEVTV | 41 | O75310 | |
| IGHRVIVSDVQESFI | 996 | Q15393 | |
| EVHDEITVTRQVVIG | 96 | O95347 | |
| EVHSGQRELESVVAV | 736 | A8K0R7 | |
| VILEELIVRGHEVTV | 41 | Q6UWM9 | |
| EIEIVHISTVQILTE | 156 | Q9BQ24 | |
| EVGRIQTEEGTEVHV | 526 | P52739 | |
| SQEVEIVEEHVTSLG | 356 | Q9C0G0 | |
| TILEELVQRGHEVTV | 41 | P54855 | |
| VEVLSDRGHEIVVVV | 46 | P19224 | |
| TILKELVQRGHEVTV | 41 | Q9BY64 | |
| TILDELIQRGHEVTV | 41 | P16662 | |
| TVIEAVKVLIEHGVQ | 246 | Q96BW1 | |
| TILEELVQRGHEVIV | 41 | O75795 | |
| LQTLGAETVVDVELH | 316 | Q9ULM3 | |
| LEEHEESLVGRAQVV | 261 | Q14789 | |
| EKVHLEETIGEIQVT | 2151 | Q14789 |